The Phase 2 oral readout showed up to 12% mean body weight reduction after 13 weeks
Recent large-scale clinical trials have been conducted to verify the weight loss effects of GLP-1RAs, especially liraglutide and semaglutide, in patients without diabetes [12, 13], which showed statistically significant weight loss when compared with lifestyle modification only
Fortunately, targeted dietary modifications, lifestyle adjustments, and medical strategies can significantly reduce GLP-1-related bloating
The team focused on two areas in the brain stem where GLP-1 drugs have a big effect
Every body responds differently to these drugs, and its possible that youll need to make other protein or dietary tweaks to feel good and protect your health long-term
Garvey WT, Mechanick JI, Brett EM, et al